Position in NTRA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,436,535
-$1,617,262 QoQ
Shares Held
8,976
-55.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#345
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fideuram Asset Management (Ireland) dac holds $60,179,417 across 14 Diagnostics & Research names. NTRA ranks #9 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
123,774 | $16,440,900 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
14,772 | $7,776,571 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12,664 | $6,349,223 | |
| 4 | DGX |
Quest Diagnostics Inc
|
27,921 | $5,917,855 | |
| 5 | ILMN |
Illumina, Inc.
|
25,847 | $4,544,678 | |
| 6 | DHR |
Danaher Corp /De/
|
23,206 | $4,420,278 | |
| 7 | WAT |
Waters Corp /De/
|
11,359 | $4,260,079 | |
| 8 | GH |
Guardant Health, Inc.
|
20,551 | $3,083,266 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,436,535 | 8,976 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $4,053,797 | 20,270 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $458 | 2 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||